Read Archives - RemedyOne

Weighing the Pros and Cons, and Dollars and Cents, of the New Wave of Weight-Loss Drugs

Clinical Insights / By Jason Peterson, R.Ph.

See this article by RemedyOne senior manager of formulary development Jason Peterson as it originally appeared in pharmaphorum and read the Goodroot weight loss drug guide it’s based on. Obesity rates in the United States have tripled since the 1980s. According to the CDC, a mind-boggling 41.9% of adults were obese as of 2020. Many …

Weighing the Pros and Cons, and Dollars and Cents, of the New Wave of Weight-Loss Drugs Read More »

Navigating the Dry Eye Landscape: Advances, Options, and Access

Clinical Insights / By Emily Crisano, Pharm.D., R.Ph.

Have you ever had that annoying gritty feeling, like there’s sand trapped in your eyes? That’s just a glimpse of what people with dry eye disease (DED) experience. Beyond the feeling of grittiness, they often battle with symptoms like redness, burning and itchiness. Over time, these pesky issues can really throw a wrench in day-to-day …

Navigating the Dry Eye Landscape: Advances, Options, and Access Read More »

The Public Health Emergency Has Ended, Now What?

Clinical Insights / By Rob Louie, RPh, MBA

The Biden Administration ended the COVID-19 Public Health Emergency (PHE) on May 11, 2023. This marks over 3 years since the Public Health Emergency (PHE) was first enacted in January of 2020. While the COVID-19 pandemic may seem to be a distant memory to some, it was attributed to nearly 7 million deaths worldwide, including …

The Public Health Emergency Has Ended, Now What? Read More »

Treating Hemophilia With Gene Therapy is a Powerful Option, But Patients Only Get One Chance

Clinical Insights / By Jason Peterson, R.Ph.

See this article by RemedyOne’s Jason Peterson as it originally appeared in Pharmaphorum. Gene therapy has emerged as a novel approach in treating haemophilia. Rather than simply managing the disorder, this technique aims to correct an abnormality or malfunction in the patient’s body by using a vector to deliver corrected genetic material. While not considered …

Treating Hemophilia With Gene Therapy is a Powerful Option, But Patients Only Get One Chance Read More »

Pharmacogenetics and Pharmacogenomics: The Future of Precision Medicine

Clinical Insights, Formulary Management / By Jason Peterson, R.Ph.

Over the past five years, Sally struggled with depression, and despite trying various treatments, none seemed to benefit her. Recently, she visited a new psychiatrist who conducted a saliva swab for pharmacogenetic testing during her initial consultation. By combining Sally’s medication history and the pharmacogenetic test results, the psychiatrist discovered that several previously prescribed medications …

Pharmacogenetics and Pharmacogenomics: The Future of Precision Medicine Read More »

Potent Veterinary Drug Resistant to Narcan and It’s Rising Illicit Use Among Humans – RemedyOne’s Rob Louie Quoted in an Insightful Analysis with Fox News

Clinical Insights, News / By RemedyOne

A Fox News article recently quoted RemedyOne EVP of clinical services Rob Louie on xylazine, a potent veterinary drug that has seen a recent uptick in illicit human use. Rob helped add context to an alert from the U.S. Drug Enforcement Administration on xylazine. Below is the complete interview, which Rob prepared for in collaboration …

Potent Veterinary Drug Resistant to Narcan and It’s Rising Illicit Use Among Humans – RemedyOne’s Rob Louie Quoted in an Insightful Analysis with Fox News Read More »

Hemophilia Gene Therapies: Are the World’s Most Expensive Drugs Really Worth It?

Clinical Insights, Formulary Management / By Jason Peterson, R.Ph.

Hemgenix became the most expensive drug in the history of FDA-approvals back in November of 2022 after the manufacturer, CSL Behring, hung a $3.5 million dollar price tag on it. This was a first-of-its-kind therapy approved for the treatment of hemophilia, more specifically hemophilia B. Hemgenix is one of the newest agents utilizing gene therapy …

Hemophilia Gene Therapies: Are the World’s Most Expensive Drugs Really Worth It? Read More »

What Is a Cough Medicine Doing in My Anti-depressant?

Clinical Insights, Formulary Management / By Jason Peterson, R.Ph.

This might come as a surprise to some individuals as they dive into the listed ingredients of the newest FDA-approved anti-depressant to hit the market, Auvelity. Let’s take a look at this new product and how a cough medicine found its way into this new treatment. Auvelity is a combination product that contains dextromethorphan (yes, …

What Is a Cough Medicine Doing in My Anti-depressant? Read More »

Whitepaper: Breaking Down the Hottest Topic in Pharmacy—Humira Biosimilars

Clinical Insights, Formulary Management / By RemedyOne

The industry report you’ve been waiting for. Today biosimilars seem to be the topic of conversation everywhere. Why? Humira. The launch of Humira biosimilars will be a test for industry stakeholders, as their entrance will reveal whether blockbuster drugs—that offer significant rebates—can be replaced to reduce the cost burden on patients and payers in the United States. Download our …

Whitepaper: Breaking Down the Hottest Topic in Pharmacy—Humira Biosimilars Read More »

Unpacking the Biosimilar Buzz

Clinical Insights, Formulary Management / By RemedyOne

As industry experts, it’s the number one topic we’re being asked to comment on. While biosimilars have existed for many years, the topic has been gaining some serious new attention as AbbVie’s Humira—the number one selling drug in the U.S.—no longer has exclusivity in the market. Will biosimilar competitors increase competition, lower drug costs and …

Unpacking the Biosimilar Buzz Read More »